- 英文名称
- Landiolol hydrochloride
- 分子式
- C25H40ClN3O8
- 分子量
- 546.06
- 中文别名
- [(4S)-2,2-二甲基-1,3-二氧戊环-4-基]甲基 3-[4-[(2S)-2-羟基-3-[2-(吗啉-4-甲酰氨基)乙基氨基]丙氧基]苯基]丙酸酯盐酸盐; 酸兰地洛尔; 兰地洛尔(盐酸盐); 盐酸兰诺醇; ((S)-2,2-二甲基-1,3-二氧戊环-4-基)甲基3-(4-((S)-2-羟基-3-((2-(吗啉-4-甲酰胺基)乙基))氨基)丙氧基)苯基)丙酸盐酸盐; ((S)-2,2-二甲基-1,3-二氧杂环戊烷-4-基)甲基 3-(4-((S)-2-羟基-3-((2-(吗啉-4-甲酰胺基)乙基)氨基)丙氧基)苯基)丙酸酯 盐酸盐; ((S)-2,2-二甲基-1,3-二氧戊环-4-基)甲基 3-(4-((S)-2-羟基-3-((2-(吗啉-4-甲酰氨基)乙基)氨基)丙氧基)苯基)丙酸酯 盐酸盐; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate hydrochloride; Benzenepropanoic acid, 4-(2-hydroxy-3-((2-((4-morpholinylcarbonyl)amino)ethyl)amino)propoxy)-, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl ester, (S-(R*,R*))-, hydrochloride; Ono 1101 hydrochloride; ((S)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((S)-2-hydroxy-3-(2-(morpholine-4-carboxamido)ethylamino)propoxy)phenyl)propanoate hydrochloride; (-)-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl-3-[4-[(S)-2-hydroxy-3-(2-morpholinocarbonylamino)ethylamino]propoxy]phenylpropionic acid hydrochloride; (-)-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(S)-2-hydroxy-3-(2-(morpholinocarbonylamino)ethylamino)propoxy]phenyl]propionate monohydrochloride; Landiololhydrochloride; 2,2-dimethyl-1,3-dioxolan-4S-yl-methyl 3-[P-{3-{(2-(morpholinocarbonylamino)ethyl)amino}-2S-hydroxypropoxy}phenyl] propionate hydrochloride; Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, hydrochloride (1:1); [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl 3-{4-[(2S)-2-hydroxy-3-({2-[(4-morpholinylcarbonyl)amino]ethyl}amino)propoxy]phenyl}propanoate hydrochloride (1:1)
- 用途
- 生命科学领域，作为超短效高选择性β1受体阻断剂，主要拮抗心脏β1受体，抑制儿茶酚胺引起的心搏增加，改善心动过速性心律失常（包括心房纤颤、心房扑动、窦性心动过速），用于手术时及手术后循环动态监视下的紧急治疗；还可用于预防CABG后房颤、控制二尖瓣收缩期前向运动、稳定血液动力学、神经保护及改善败血症等。
